Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Post-transplant malignancy in solid organ transplant recipients in Ireland The Irish Transplant Cancer Group.

O'Neill JP, Sexton DJ, O'Leary E, O'Kelly P, Murray S, Deady S, Daly F, Williams Y, Dean B, Fitzgerald C, Murad A, Mansoor N, O'Neill JO, Egan J, Houlihan DD, McCormick PA, Morris PG, Ni Raghallaigh S, Little D, Moloney FJ, Conlon PJ.

Clin Transplant. 2019 Jul 16:e13669. doi: 10.1111/ctr.13669. [Epub ahead of print]

PMID:
31310037
2.

Artificial Intelligence in Dermatology-Where We Are and the Way to the Future: A Review.

Hogarty DT, Su JC, Phan K, Attia M, Hossny M, Nahavandi S, Lenane P, Moloney FJ, Yazdabadi A.

Am J Clin Dermatol. 2019 Jul 5. doi: 10.1007/s40257-019-00462-6. [Epub ahead of print] Review.

PMID:
31278649
3.

Mammalian target of rapamycin (mTOR) inhibitors and skin cancer risk in nonrenal solid organ transplant recipients: systematic review and meta-analysis.

Phan K, Moloney FJ, Hogarty DT, Lenane P, McColl D, Yazdabadi A.

Int J Dermatol. 2019 Jun 22. doi: 10.1111/ijd.14549. [Epub ahead of print]

PMID:
31228256
4.

Merkel cell carcinoma in kidney transplant recipients in Ireland 1964-2018.

Keeling E, Murray SL, Williams Y, Sexton DJ, O'Kelly P, Deady S, O'Leary E, Dorman A, Roche M, Ni Raghallaigh S, McCormick A, Moloney FJ, O'Neill JP, Conlon PJ.

Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18218. [Epub ahead of print] No abstract available.

PMID:
31206594
5.

Declining Incidence of Keratinocyte Carcinoma in Organ Transplant Recipients.

Menzies S, 'Leary EO, Callaghan G, Galligan M, Deady S, Gadallah B, Lenane P, Lally A, Houlihan DD, Morris PG, Sexton DJ, McCormick PA, Egan JJ, O'Neill JP, Conlon PJ, Moloney FJ.

Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18094. [Epub ahead of print]

PMID:
31049932
6.

Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.

Sexton DJ, O'Kelly P, O'Leary E, Murray S, Deady S, Daly F, Egan J, Houlihan DD, McCormick PA, Morris PG, Ni Raghallaigh S, Moloney FJ, O'Neill JP, Conlon PJ.

JAMA Dermatol. 2019 May 1;155(5):594-598. doi: 10.1001/jamadermatol.2018.4660.

PMID:
30725084
7.

Pigmented purpura masquerading as acral melanoma.

Callaghan GM, Woods G, Menzies S, Moloney FJ.

Australas J Dermatol. 2019 Feb;60(1):e68-e70. doi: 10.1111/ajd.12885. Epub 2018 Jul 5. No abstract available.

PMID:
29974454
8.

Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.

Hambly RA, Mansoor N, Quinlan C, Shah Z, Lenane P, Ralph N, Moloney FJ.

Photodermatol Photoimmunol Photomed. 2017 May;33(3):176-179. doi: 10.1111/phpp.12301. Epub 2017 Mar 28. No abstract available.

PMID:
28196277
9.

Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.

Hambly R, Mansoor N, Quinlan C, Shah Z, Lenane P, Ralph N, Moloney FJ.

Br J Dermatol. 2017 Sep;177(3):e55-e57. doi: 10.1111/bjd.15281. Epub 2017 Jul 9. No abstract available.

PMID:
28028807
10.

Segmental pityriasis rosea within the area of BRAF-mutated metastatic melanoma.

Murad A, Ralph N, Mulligan N, Moloney FJ.

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e133-e134. doi: 10.1111/jdv.13410. Epub 2015 Oct 7. No abstract available.

PMID:
26446380
11.

Blistering psoriatic plaques during narrowband UVB phototherapy.

Fahy CM, McDonald I, Gaynor L, Murphy GM, Mulligan N, Lenane P, Moloney FJ.

Photodermatol Photoimmunol Photomed. 2015 May;31(3):167-9. doi: 10.1111/phpp.12167. Epub 2015 Mar 3. No abstract available.

PMID:
25684540
12.

Vismodegib in the treatment of advanced BCC.

O'Kane GM, Lyons T, McDonald I, Mulligan N, Moloney FJ, Murray D, Kelly CM.

Ir Med J. 2014 Jul-Aug;107(7):215-6.

PMID:
25226719
13.

Two cases of dermatoses koebnerizing within fields of previous radiotherapy.

Hellen R, Kiely C, Murad A, Mulligan N, Coffey J, Lenane P, Moloney FJ.

Clin Exp Dermatol. 2014 Dec;39(8):900-3. doi: 10.1111/ced.12421. Epub 2014 Sep 15.

PMID:
25224250
14.

Violaceous perivulvar nodular eruption after chemotherapy.

Murad A, Fortune A, Moloney FJ.

JAMA Dermatol. 2014 Sep;150(9):1003-4. doi: 10.1001/jamadermatol.2014.547. No abstract available.

PMID:
25007316
15.

Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.

Moloney FJ, Guitera P, Coates E, Haass NK, Ho K, Khoury R, O'Connell RL, Raudonikis L, Schmid H, Mann GJ, Menzies SW.

JAMA Dermatol. 2014 Aug;150(8):819-27. doi: 10.1001/jamadermatol.2014.514.

PMID:
24964862
16.

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Cho EA, Moloney FJ, Cai H, Au-Yeung A, China C, Scolyer RA, Yosufi B, Raftery MJ, Deng JZ, Morton SW, Hammond PT, Arkenau HT, Damian DL, Francis DJ, Chesterman CN, Barnetson RS, Halliday GM, Khachigian LM.

Lancet. 2013 May 25;381(9880):1835-43. doi: 10.1016/S0140-6736(12)62166-7. Epub 2013 May 7.

17.

Dermoscopic evaluation of nodular melanoma.

Menzies SW, Moloney FJ, Byth K, Avramidis M, Argenziano G, Zalaudek I, Braun RP, Malvehy J, Puig S, Rabinovitz HS, Oliviero M, Cabo H, Bono R, Pizzichetta MA, Claeson M, Gaffney DC, Soyer HP, Stanganelli I, Scolyer RA, Guitera P, Kelly J, McCurdy O, Llambrich A, Marghoob AA, Zaballos P, Kirchesch HM, Piccolo D, Bowling J, Thomas L, Terstappen K, Tanaka M, Pellacani G, Pagnanelli G, Ghigliotti G, Ortega BC, Crafter G, Ortiz AM, Tromme I, Karaarslan IK, Ozdemir F, Tam A, Landi C, Norton P, Kaçar N, Rudnicka L, Slowinska M, Simionescu O, Di Stefani A, Coates E, Kreusch J.

JAMA Dermatol. 2013 Jun;149(6):699-709. doi: 10.1001/jamadermatol.2013.2466.

PMID:
23553375
18.

Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy.

Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, Fogarty G, Scolyer RA.

JAMA Dermatol. 2013 Jun;149(6):692-8. doi: 10.1001/jamadermatol.2013.2301.

PMID:
23553208
19.

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.

Khachigian LM, Cai H, Moloney FJ, Parish CR, Chong BH, Stocker R, Barnetson RS, Halliday GM.

Oncotarget. 2012 Jun;3(6):594-5.

20.

DNAzyme targeting c-jun suppresses skin cancer growth.

Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, Lieschke GJ, Wong TW, Chesterman CN, Francis DJ, Moloney FJ, Barnetson RS, Halliday GM, Khachigian LM.

Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960.

21.

Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.

Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL.

J Invest Dermatol. 2012 May;132(5):1497-500. doi: 10.1038/jid.2011.459. Epub 2012 Feb 2. No abstract available.

22.

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

Bock VL, Lyons JG, Huang XX, Jones AM, McDonald LA, Scolyer RA, Moloney FJ, Barnetson RS, Halliday GM.

Br J Dermatol. 2011 Jun;164(6):1221-7. doi: 10.1111/j.1365-2133.2011.10267.x. Epub 2011 May 13.

PMID:
21564052
23.

Trigeminal trophic syndrome treated with thermoplastic occlusion.

Kurien AM, Damian DL, Moloney FJ.

Australas J Dermatol. 2011 Feb;52(1):e1-4. doi: 10.1111/j.1440-0960.2009.00613.x.

PMID:
21332680
24.

Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma.

Moloney FJ, Menzies SW.

J Dermatol. 2011 Jan;38(1):10-5. doi: 10.1111/j.1346-8138.2010.01140.x. Review.

PMID:
21175750
25.

Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility.

Cocciolone RA, Crotty KA, Andrews L, Haass NK, Moloney FJ.

Arch Dermatol. 2010 Nov;146(11):1316-8. doi: 10.1001/archdermatol.2010.333. No abstract available.

PMID:
21079084
26.

Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.

Undre NA, Moloney FJ, Ahmadi S, Stevenson P, Murphy GM.

Br J Dermatol. 2009 Mar;160(3):665-9. doi: 10.1111/j.1365-2133.2008.08974.x. Epub 2008 Dec 12.

PMID:
19076975
27.

Hotspot mutation of Brahma in non-melanoma skin cancer.

Moloney FJ, Lyons JG, Bock VL, Huang XX, Bugeja MJ, Halliday GM.

J Invest Dermatol. 2009 Apr;129(4):1012-5. doi: 10.1038/jid.2008.319. Epub 2008 Oct 16.

28.

SWI/SNF: a chromatin-remodelling complex with a role in carcinogenesis.

Halliday GM, Bock VL, Moloney FJ, Lyons JG.

Int J Biochem Cell Biol. 2009 Apr;41(4):725-8. doi: 10.1016/j.biocel.2008.04.026. Epub 2008 Aug 3. Review.

PMID:
18723114
29.

Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin.

Moloney FJ, Hughes R, O'Shea D, Kirby B.

Clin Exp Dermatol. 2008 Jul;33(4):412-4. doi: 10.1111/j.1365-2230.2007.02584.x. Epub 2008 May 21.

PMID:
18498413
30.

Improved renal allograft survival with vitamin D receptor polymorphism.

Lavin PJ, Laing ME, O'Kelly P, Moloney FJ, Gopinathan D, Aradi AA, Shields DC, Murphy GM, Conlon PJ.

Ren Fail. 2007;29(7):785-9.

PMID:
17994444
31.

Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients.

Laing ME, Dicker P, Moloney FJ, Ho WL, Murphy GM, Conlon P, Whitehead AS, Shields DC.

Transplantation. 2007 Jul 15;84(1):113-6.

PMID:
17627246
33.

Life imitating art.

Moloney FJ, Rogers S.

Br J Dermatol. 2007 May;156(5):1086. Epub 2007 Mar 28. No abstract available.

PMID:
17388927
34.

Bilateral lower limb erythematous papules with myalgia.

Moloney FJ, Hayden J, Sheahan K, Collins P.

Clin Exp Dermatol. 2007 Jul;32(4):475-6. Epub 2007 Jan 30. No abstract available.

PMID:
17263832
35.

Legibility of doctor's signatures: novel approaches to improving an age-old problem.

Daly P, Moloney FJ, Doyle M, O'Mahony JB.

Ir Med J. 2006 Jul-Aug;99(7):214-5.

PMID:
16986568
36.

Malignant melanoma in renal transplant recipients.

Laing ME, Moloney FJ, Comber H, Conlon P, Murphy GM.

Br J Dermatol. 2006 Oct;155(4):857. No abstract available.

PMID:
16965451
37.

Malignant melanoma in transplant patients: review of five cases.

Laing ME, Moloney FJ, Kay EW, Conlon P, Murphy GM.

Clin Exp Dermatol. 2006 Sep;31(5):662-4.

PMID:
16780495
38.

The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.

Moloney FJ, Dicker P, Conlon PJ, Shields DC, Murphy GM.

Br J Dermatol. 2006 Jun;154(6):1199-200. No abstract available.

PMID:
16704656
39.

The role of immunosuppression in the pathogenesis of basal cell carcinoma.

Moloney FJ, Comber H, Conlon PJ, Murphy GM.

Br J Dermatol. 2006 Apr;154(4):790-1. No abstract available.

PMID:
16536838
40.

A population-based study of skin cancer incidence and prevalence in renal transplant recipients.

Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM.

Br J Dermatol. 2006 Mar;154(3):498-504.

PMID:
16445782
41.

Mutation analysis in Irish families with glomuvenous malformations.

O'Hagan AH, Moloney FJ, Buckley C, Bingham EA, Walsh MY, McKenna KE, McGibbon D, Hughes AE.

Br J Dermatol. 2006 Mar;154(3):450-2. Erratum in: Br J Dermatol. 2006 Apr;154(4):807. Maloney, F [corrected to Moloney, FJ].

PMID:
16445774
42.

Iatrogenic phytophotodermatitis resulting from herbal treatment of an allergic contact dermatitis.

Moloney FJ, Parnell J, Buckley CC.

Clin Exp Dermatol. 2006 Jan;31(1):39-41.

PMID:
16309477
43.

The impact of skin disease following renal transplantation on quality of life.

Moloney FJ, Keane S, O'Kelly P, Conlon PJ, Murphy GM.

Br J Dermatol. 2005 Sep;153(3):574-8.

PMID:
16120145
44.

Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients.

Moloney FJ, Almarzouqi E, O'Kelly P, Conlon P, Murphy GM.

Arch Dermatol. 2005 Aug;141(8):978-82.

PMID:
16103326
45.

Renal transplantation, immunosuppression and the skin: an update.

Moloney FJ, de Freitas D, Conlon PJ, Murphy GM.

Photodermatol Photoimmunol Photomed. 2005 Feb;21(1):1-8. Review.

PMID:
15634217
46.

Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma.

Moloney FJ, Kelly PO, Kay EW, Conlon P, Murphy GM.

Dermatol Surg. 2004 Apr;30(4 Pt 2):674-8.

PMID:
15061854
47.

Case 3. Acne agminata (lupus miliaris disseminatus faciei).

Moloney FJ, Egan CA.

Clin Exp Dermatol. 2003 Nov;28(6):685-6. No abstract available.

PMID:
14616852
48.

Sunscreens: safety, efficacy and appropriate use.

Moloney FJ, Collins S, Murphy GM.

Am J Clin Dermatol. 2002;3(3):185-91. Review.

PMID:
11978139

Supplemental Content

Loading ...
Support Center